Postpartum Acupressure Education and Breastfeeding Outcomes
Effect of Postpartum Acupressure Education on Breastfeeding Outcomes: A 12-Month Randomized Controlled Trial
Nigde Omer Halisdemir University
360 participants
Apr 25, 2026
INTERVENTIONAL
Conditions
Summary
This randomized controlled trial evaluates whether acupressure education provided to mothers within the first 48 hours postpartum improves exclusive breastfeeding rates at 6 months compared with standard postpartum care alone. Mothers in the intervention group will receive structured education on self-administered acupressure at selected points and will be encouraged to continue home-based practice, while the control group will receive standard breastfeeding support. Participants will be followed for 12 months to assess breastfeeding continuation, breastfeeding self-efficacy, breastfeeding quality, and breastfeeding-related outcomes.
Eligibility
Inclusion Criteria7
- Age 18 to 45 years
- Term singleton birth (≥37 weeks of gestation)
- ≤48 hours postpartum at the time of enrollment
- Intention to breastfeed
- Ability to communicate in Turkish
- Access to a smartphone for educational materials and follow-up reminders
- Willingness to provide written informed consent
Exclusion Criteria6
- Contraindications to breastfeeding (e.g., infant galactosemia)
- Severe neonatal condition preventing breastfeeding
- Severe maternal medical or psychiatric condition interfering with breastfeeding
- Current opioid, alcohol, or substance dependence
- Multiple gestation pregnancy
- Severe breast injury or condition within the first 72 hours postpartum preventing breastfeeding
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Structured education on self-administered acupressure provided within 48 hours postpartum, including face-to-face instruction, printed visual materials, and a short instructional video. Participants are instructed to apply acupressure at specified points twice daily at home according to the study protocol.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07410949